Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

ATIC

Identity

Other namesPURH
AICARFT/IMPCHASE (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase)
AICARFT
IMPCHASE
Hugo ATIC
Location 2q35
 
  ATIC (2p35) - Courtesy Mariano Rocchi, Resources for Molecular Cytogenetics. Laboratories willing to validate the probes are welcome : contact rocchi@biologia.uniba.it

DNA/RNA

Transcription 1776 bp mRNA; transcribed in a centromeric to telomeric orientation

Protein

Description 591 amino acids, 64 kDa; two functional domains separated by a linker region with a dimerization domain (amino acids 170 to 199): amino acids 1 to 169 encode the IMP cyclohydrolase (IMPCH) function, and amino acids 200 to 591 encode the 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFT) function; homodimer
Expression wide
Function bifunctional purine biosythesis:9th and 10th step of the de novo purine synthesis
Homology belongs to the PURH family

Implicated in

Entity inv(2)(p23q35) --> ATIC- ALK
Disease found in rare cases of ALK+ anaplasic large cell lymphoma
Cytogenetics hidden translocation most often
Hybrid/Mutated Gene 5' ATIC - 3' ALK
Abnormal Protein 791 amino acids, 87 kDa. 229 N-term amino acid from ATIC containing the IMPCH domain and the dimerization domain fused to the 562 C-term amino acids from ALK (i.e. the entire cytoplasmic portion of ALK with the tyrosine kinase domain); cytoplasmic localisation only.
Oncogenesis ATIC seems to provoke the dimerization of ATIC-ALK, which should lead to constitutive autophosphorylation and activation of the ALK tyrosine kinase, as for NPM1-ALK (see t(2;5)(p23;q35) ).
  

External links

Nomenclature
HugoATIC
GDBATIC
Entrez_GeneATIC  471  5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
Cards
AtlasATICID227
GeneCardsATIC
EnsemblATIC [Search_View]   ENSG00000138363 [Gene_View]
GenatlasATIC
GeneLynxATIC
eGenomeATIC
euGene471
Genomic and cartography
GoldenPathATIC  -  2q35   chr2:215885081-215922722 +  2q35   [Description]    (hg18-Mar_2006)
EnsemblATIC - 2q35 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneATIC
Gene and transcription
GenbankAB062403 [ ENTREZ ]
GenbankAK290067 [ ENTREZ ]
GenbankBC008879 [ ENTREZ ]
GenbankCR594366 [ ENTREZ ]
GenbankCR600478 [ ENTREZ ]
RefSeqNM_004044 [ SRS ]    NM_004044 [ ENTREZ ]
RefSeqAC_000045 [ SRS ]    AC_000045 [ ENTREZ ]
RefSeqNC_000002 [ SRS ]    NC_000002 [ ENTREZ ]
RefSeqNT_005403 [ SRS ]    NT_005403 [ ENTREZ ]
RefSeqNW_921618 [ SRS ]    NW_921618 [ ENTREZ ]
AceViewATIC AceView - NCBI
UnigeneHs.90280 [ SRS ]    Hs.90280 [ NCBI ]     HS90280 [ spliceNest ]
Fast-db14937 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtP31939 [ SRS]    P31939 [ EXPASY ]     P31939 [ INTERPRO ]
InterproIPR002695 AICARFT_IMPCHas [ SRS ]    IPR002695 AICARFT_IMPCHas [ EBI ]
InterproIPR013982 AICARFT_IMPCHas_formly [ SRS ]    IPR013982 AICARFT_IMPCHas_formly [ EBI ]
InterproIPR011607 MGS [ SRS ]    IPR011607 MGS [ EBI ]
CluSTrP31939
PfamPF01808 AICARFT_IMPCHas [ SRS ]    PF01808 AICARFT_IMPCHas [ Sanger ]    pfam01808 [ NCBI-CDD ]
PfamPF02142 MGS [ SRS ]    PF02142 MGS [ Sanger ]    pfam02142 [ NCBI-CDD ]
SmartSM00798 AICARFT_IMPCHas [EMBL]
BlocksP31939
PDB1P4R [ SRS ]    1P4R [ PdbSum ],   1P4R [ IMB ]   1P4R [ RSDB ]
PDB1PKX [ SRS ]    1PKX [ PdbSum ],   1PKX [ IMB ]   1PKX [ RSDB ]
PDB1PL0 [ SRS ]    1PL0 [ PdbSum ],   1PL0 [ IMB ]   1PL0 [ RSDB ]
HPRD03434
Protein Interaction databases
DIPP31939
IntActP31939
Polymorphism : SNP, mutations, diseases
OMIM601731;608688    [ map ]   
GENECLINICS601731;608688
SNPATIC [dbSNP-NCBI]  
SNPNM_004044 [SNP-NCI]  
SNPATIC [GeneSNPs - Utah]  ATIC] [HGBASE - SRS]
HAPMAPATIC [HAPMAP]  
COSMICATIC [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDATIC
General knowledge
Family BrowserATIC [UCSC Family Browser]
SOURCENM_004044
SMDHs.90280
SAGEHs.90280
Enzyme2.1.2.3 [ Enzyme-SRS ]   2.1.2.3 [ Brenda-SRS ]   2.1.2.3 [ KEGG ]   2.1.2.3 [ WIT ]
GOIMP cyclohydrolase activity [Amigo]  IMP cyclohydrolase activity
GOphosphoribosylaminoimidazolecarboxamide formyltransferase activity [Amigo]  phosphoribosylaminoimidazolecarboxamide formyltransferase activity
GOprotein binding [Amigo]  protein binding
GOnucleobase, nucleoside, nucleotide and nucleic acid metabolic process [Amigo]  nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
GOpurine nucleotide biosynthetic process [Amigo]  purine nucleotide biosynthetic process
GOIMP biosynthetic process [Amigo]  IMP biosynthetic process
GOtransferase activity [Amigo]  transferase activity
GOhydrolase activity [Amigo]  hydrolase activity
GOorgan regeneration [Amigo]  organ regeneration
KEGGPurine metabolism
KEGGOne carbon pool by folate
PubGeneATIC
TreeFamATIC
CTD471 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeCancer Cytogenetics (Bari)
ProbeATIC Related clones (RZPD - Berlin)
PubMed
PubMed14 Pubmed reference(s) in LocusLink

Bibliography

The human purH gene product, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase. Cloning, sequencing, expression, purification, kinetic analysis, and domain mapping.
Rayl EA, Moroson BA, Beardsley GP
The Journal of biological chemistry. 1996 ; 271 (4) : 2225-2233.
PMID 8567683
 
Characterization of molecularly cloned human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase.
Sugita T, Aya H, Ueno M, Ishizuka T, Kawashima K
Journal of biochemistry. 1997 ; 122 (2) : 309-313.
PMID 9378707
 
Structure and functional relationships in human pur H.
Beardsley GP, Rayl EA, Gunn K, Moroson BA, Seow H, Anderson KS, Vergis J, Fleming K, Worland S, Condon B, Davies J
Advances in experimental medicine and biology. 1998 ; 431 : 221-226.
PMID 9598063
 
ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).
Colleoni GW, Bridge JA, Garicochea B, Liu J, Filippa DA, Ladanyi M
The American journal of pathology. 2000 ; 156 (3) : 781-789.
PMID 10702393
 
Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis.
Ma Z, Cools J, Marynen P, Cui X, Siebert R, Gesk S, Schlegelberger B, Peeters B, De Wolf-Peeters C, Wlodarska I, Morris SW
Blood. 2000 ; 95 (6) : 2144-2149.
PMID 10706887
 
CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H, Foss HD, Dˆºrkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B
Blood. 2000 ; 96 (12) : 3681-3695.
PMID 11090048
 
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
Trinei M, Lanfrancone L, Campo E, Pulford K, Mason DY, Pelicci PG, Falini B
Cancer research. 2000 ; 60 (4) : 793-798.
PMID 10706082
 
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. 2000 ; 14 (9) : 1533-1559.
PMID 10994999
 
Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma.
Morris SW, Xue L, Ma Z, Kinney MC
British journal of haematology. 2001 ; 113 (2) : 275-295.
PMID 11380391
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written08-2001Jean-Loup Huret

Citation

This paper should be referenced as such :
Huret JL . ATIC. Atlas Genet Cytogenet Oncol Haematol. August 2001 .
URL : http://AtlasGeneticsOncology.org/Genes/ATICID227.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jul 2 08:21:59 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.